Mettu, Niharika B. http://orcid.org/0000-0002-7821-3298
Niedzwiecki, Donna
Rushing, Christel
Nixon, Andrew B.
Jia, Jingquan
Haley, Sherri
Honeycutt, Wanda
Hurwitz, Herbert
Bendell, Johanna C.
Uronis, Hope
Funding for this research was provided by:
Bristol-Myers Squibb
National Institutes of Health (5K24-CA113755-05)
Article History
Received: 8 January 2019
Accepted: 22 February 2019
First Online: 20 March 2019
Compliance with ethical standards
:
: NBM is a clinical investigator on clinical trials supported by Incyte, ARMO, OncoMed, and Genentech/Roche. HU is a clinical investigator on clinical trials supported by Macrogenics, Merck, Genentech/Roche. ABN reports honoraria for consulting and advisory boards for Eli Lilly, Pfizer, and Kanghong Pharma. He has received grant support from Acceleron Pharma, Amgen, AstraZeneca/MedImmune, Eureka Therapeutics, Genentech, Leadiant Biosciences, MedPacto Inc, Novartis, Seattle Genetics, and Tracon Pharma. HH is employed by Genentech/Roche. The remaining authors have no conflicts of interest.